Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conventional and Scientific uses of Rice-washed water: A Systematic Review.
Chithambharan A, Pottail L, Sharma SC, Mirle RM, Rajalakshmi R, Ponnusamy A. Chithambharan A, et al. Among authors: ponnusamy a. J Food Sci Technol. 2024 Mar;61(3):414-428. doi: 10.1007/s13197-023-05722-2. Epub 2023 Mar 17. J Food Sci Technol. 2024. PMID: 38327867 Review.
IgA vasculitis nephritis-outcomes in adult-onset disease.
Stanway J, Brown N, Pervez A, Van de Perre E, Tollitt J, Marketos N, Wong N, Dhaygude A, Ponnusamy A, O'Riordan E, Venning M, Segelmark M, Morgan M, Jayne D, Hamilton P, Pusey CD, Oni L, Salama AD. Stanway J, et al. Among authors: ponnusamy a. Rheumatology (Oxford). 2024 Jan 25:keae030. doi: 10.1093/rheumatology/keae030. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38273659
Is home dialysis an optimal option during pregnancy?
Moore L, Wu HHL, Ponnusamy A. Moore L, et al. Among authors: ponnusamy a. Ther Apher Dial. 2024 Jun;28(3):467-468. doi: 10.1111/1744-9987.14095. Epub 2023 Dec 12. Ther Apher Dial. 2024. PMID: 38084647 No abstract available.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
59 results